GERD Drug and Devices Market by Device/Drug Type, Route of Administration & End-User – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2029

2.3%
CAGR (2023-2029)
4.01 USD Bn.
Market Size
300
Report Pages
149
Market Tables

Overview

GERD Drug and Devices Market is expected to grow at a CAGR of 2.3% during the forecast period and market is expected to reach US$ 4.71 Bn. by 2029.

GERD Drug and Devices Market Overview

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.GERD Drug and Devices Market

To know about the Research Methodology :- Request Free Sample Report

Gastro-esophageal reflux disease (GERD) is a chronic digestive disorder that occurs due to complications arising in the esophagus. Gastro-esophageal reflux disease is a chronic and highly prevalent medical problem.

GERD Drug and Devices Market dynamics

The GERD Drug and Devices Market growth is driven by increasing awareness about GERD and a slopping trend toward self-medication, a rise in the occurrence of the disorders related to GERD. Changing lifestyles huge consumption of fast food, drinks, and alcohol and growing stress level are expected to drive the market during the forecast period. Other factors are increasing acidic taste in the mouth, heartburn, dryness and asthma are expected to fuel the demand for GERD drugs and Devices for various medications, devices and surgery.

The major driving factor of the global GERD drug and devices market is a growing trend of self-medication and increasing awareness about GERD. Additionally, increasing occurrence of GERD disorders, as well as changes in lifestyle, are also boosting the growth of the global GERD drug and devices market. Factors such as the consumption of fast food, stress, and intake of alcohol and aerated drinks are led to the rise in prevalence of GERD across the globe.

Patent expiry and an adverse effect of proton pump inhibitors are the major factors hindering the GERD drug and devices market. Due to side effects of drugs on long-term use, patients who fail to respond to medication & the development of new technology are a major opportunity of the global GERD drug and devices market.

The Gastro-esophageal reflux disease (GERD) drug and devices market is segmented into type, devices, and region.

In terms of type, global GERD drug and devices market is classified into antacids, h2 receptor blockers, proton pump inhibitors, and pro-kinetic agents. Based on a device, global GERD drug, and devices market is divided into digitrapper, bravo system, stretta, Linx reflux management system, medigus ultrasonic surgical endostapler, and other devices.

Based on regions, the global GERD drug and devices market is divided into five main regions are North America, Europe, Asia-pacific, South America and Middle East & Africa.

In terms of type, antacids are preferred as first-line therapy for mild and infrequent symptoms as they immediately neutralize gastric acid secretions. The body well absorbs H2 receptor blockers and provide quick relief from the esophagus symptoms. Proton pump inhibitors inhibit gastric acid secretion by inhibition of the H+/K+ ATPase enzyme system in the gastric parietal cells. Pro-kinetic agents, also known as promobility agents, stimulate the muscles of the gastrointestinal tract and strengthen lower esophageal sphincter, thereby reducing acid reflux into the esophagus.

Based on devices, digitrapper reflux testing system observes & records the extra-esophageal symptoms of acid reflux. The Bravo System is a diagnostic system to determine the frequency & duration of acid reflux. Medigus ultrasonic surgical endostapler is an endoscopic device used for transoral fundoplication.

GERD Drug and Devices Market Regional Insight

North America is expected to hold the xx% share during the forecast period due to the possibilities of the presence of a large patient population suffering from heartburn and the availability of OTC generics. The rise in the incidence of GERD in North America is responsible for the increase in demand for acid reducing and neutralizing drugs.

The objective of the report is to present a comprehensive analysis of the Global GERD Drug and Devices Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors in the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global GERD Drug and Devices Market dynamics, structure by analyzing the market segments and project the Global GERD Drug and Devices Market size. Clear representation of competitive analysis of key players by End-User Industry, price, financial position, Product portfolio, growth strategies, and regional presence in the Global GERD Drug and Devices Market make the report investor’s guide.

GERD Drug and devices market Scope : Inquire before buying

GERD Drug and Devices Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 4.01 Bn.
Forecast Period 2023 to 2029 CAGR: 2.3% Market Size in 2029: US $ 4.71 Bn.
Segments Covered: by Type • Antacids
• H2 Receptor Blockers
• Proton Pump Inhibitors
• Pro-Kinetic Agents
by Devices • Digitrapper
• Bravo System
• Stretta
• Linx Reflux Management System
• Medigus Ultrasonic Surgical Endostapler
• Other Devices

GERD Drug and Devices Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Key Player Operating in Global GERD Drug and devices market:

• AstraZeneca PLC
• Boston Scientific Corporation
• Cempra Inc.
• Eisai Co., Ltd.
• EndoGastric Solutions Inc.
• EndoStim Inc.
• GlaxoSmithKline Plc
• Ironwood Pharmaceuticals, Inc.
• Jeil Pharmaceutical Co. Ltd.
• Johnson & Johnson
• Mederi Therapeutics Inc.
• Medigus Ltd.
• Medtronic Inc.
• Merck & CO., Inc.
• Novartis AG
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceuticals Industries Limited.
• Torax Medical
• Valeant Pharmaceuticals International, Inc

Frequently Asked Questions:

1. Which region has the largest share in Global GERD Drug and Devices Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global GERD Drug and Devices Market?
Ans: The Global GERD Drug and Devices Market is growing at a CAGR of 2.3% during forecasting period 2023-2029.

3. What is scope of the Global GERD Drug and Devices Market report?
Ans: Global GERD Drug and Devices Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global GERD Drug and Devices Market?
Ans: The important key players in the Global GERD Drug and Devices Market are – AstraZeneca PLC, Boston Scientific Corporation, Cempra Inc., Eisai Co., Ltd., EndoGastric Solutions Inc., EndoStim Inc., GlaxoSmithKline Plc, Ironwood Pharmaceuticals, Inc., Jeil Pharmaceutical Co. Ltd., Johnson & Johnson, Mederi Therapeutics Inc., Medigus Ltd., Medtronic Inc., Merck & CO., Inc., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Limited., Torax Medical, Valeant Pharmaceuticals International, and Inc

5. What is the study period of this Market?
Ans: The Global GERD Drug and Devices Market is studied from 2022 to 2029.

Table of Contents

Global GERD Drug and Devices Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global GERD Drug and devices market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.4.Global GERD Drug and devices market Industry Trends 5. Global GERD Drug and devices market Analysis and Forecast 5.1. Global GERD Drug and devices market Analysis and Forecast 5.2. Global GERD Drug and devices market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. South America 6. Global GERD Drug and devices market Analysis and Forecast, by Type 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global GERD Drug and devices market Value Share Analysis, by Type 6.4. Global GERD Drug and devices market Size (US$ Mn) Forecast, by Type 6.5. Global GERD Drug and devices market Analysis, by Type 6.6. Global GERD Drug and devices market Attractiveness Analysis, by Type 7. Global GERD Drug and devices market Analysis and Forecast, by Devices 7.1. Introduction and Definition 7.2. Global GERD Drug and devices market Value Share Analysis, by Devices 7.3. Global GERD Drug and devices market Size (US$ Mn) Forecast, by Devices 7.4. Global GERD Drug and devices market Analysis, by Devices 7.5. Global GERD Drug and devices market Attractiveness Analysis, by Devices 8. Global GERD Drug and devices market Analysis, by Region 8.1. Global GERD Drug and devices market Value Share Analysis, by Region 8.2. Global GERD Drug and devices market Size (US$ Mn) Forecast, by Region 8.3. Global GERD Drug and devices market Attractiveness Analysis, by Region 9. North America GERD Drug and devices market Analysis 9.1. Key Findings 9.2. North America GERD Drug and devices market Overview 9.3. North America GERD Drug and devices market Value Share Analysis, by Type 9.4. North America GERD Drug and devices market Forecast, by Type 9.4.1. Antacids 9.4.2. H2 Receptor Blockers 9.4.3. Proton Pump Inhibitors 9.4.4. Pro-Kinetic Agents 9.5. North America GERD Drug and devices market Value Share Analysis, by Devices 9.6. North America GERD Drug and devices market Forecast, by Devices 9.6.1. Digitrapper 9.6.2. Bravo System 9.6.3. Stretta 9.6.4. Linx Reflux Management System 9.6.5. Medigus Ultrasonic Surgical Endostapler 9.6.6. Other Devices 9.7. North America GERD Drug and devices market Value Share Analysis, by Country 9.8. North America GERD Drug and devices market Forecast, by Country 9.8.1. U.S. 9.8.2. Canada 9.9. North America GERD Drug and devices market Analysis, by Country 9.10. U.S. GERD Drug and devices market Forecast, by Type 9.10.1. Antacids 9.10.2. H2 Receptor Blockers 9.10.3. Proton Pump Inhibitors 9.10.4. Pro-Kinetic Agents 9.11. U.S. GERD Drug and devices market Forecast, by Devices 9.11.1. Digitrapper 9.11.2. Bravo System 9.11.3. Stretta 9.11.4. Linx Reflux Management System 9.11.5. Medigus Ultrasonic Surgical Endostapler 9.11.6. Other Devices 9.12. Canada GERD Drug and devices market Forecast, by Type 9.12.1. Antacids 9.12.2. H2 Receptor Blockers 9.12.3. Proton Pump Inhibitors 9.12.4. Pro-Kinetic Agents 9.13. Canada GERD Drug and devices market Forecast, by Devices 9.13.1. Digitrapper 9.13.2. Bravo System 9.13.3. Stretta 9.13.4. Linx Reflux Management System 9.13.5. Medigus Ultrasonic Surgical Endostapler 9.13.6. Other Devices 9.14. North America GERD Drug and devices market Attractiveness Analysis 9.14.1. By Type 9.14.2. By Devices 9.15. PEST Analysis 10. Europe GERD Drug and devices market Analysis 10.1. Key Findings 10.2. Europe GERD Drug and devices market Overview 10.3. Europe GERD Drug and devices market Value Share Analysis, by Type 10.4. Europe GERD Drug and devices market Forecast, by Type 10.4.1. Antacids 10.4.2. H2 Receptor Blockers 10.4.3. Proton Pump Inhibitors 10.4.4. Pro-Kinetic Agents 10.5. Europe GERD Drug and devices market Value Share Analysis, by Devices 10.6. Europe GERD Drug and devices market Forecast, by Devices 10.6.1. Digitrapper 10.6.2. Bravo System 10.6.3. Stretta 10.6.4. Linx Reflux Management System 10.6.5. Medigus Ultrasonic Surgical Endostapler 10.6.6. Other Devices 10.7. Europe GERD Drug and devices market Value Share Analysis, by Country 10.8. Europe GERD Drug and devices market Forecast, by Country 10.8.1. Germany 10.8.2. U.K. 10.8.3. France 10.8.4. Italy 10.8.5. Spain 10.8.6. Rest of Europe 10.9. Europe GERD Drug and devices market Analysis, by Country/ Sub-region 10.10. Germany GERD Drug and devices market Forecast, by Type 10.10.1. Antacids 10.10.2. H2 Receptor Blockers 10.10.3. Proton Pump Inhibitors 10.10.4. Pro-Kinetic Agents 10.11. Germany GERD Drug and devices market Forecast, by Devices 10.11.1. Digitrapper 10.11.2. Bravo System 10.11.3. Stretta 10.11.4. Linx Reflux Management System 10.11.5. Medigus Ultrasonic Surgical Endostapler 10.11.6. Other Devices 10.12. U.K. GERD Drug and devices market Forecast, by Type 10.12.1. Antacids 10.12.2. H2 Receptor Blockers 10.12.3. Proton Pump Inhibitors 10.12.4. Pro-Kinetic Agents 10.13. U.K. GERD Drug and devices market Forecast, by Devices 10.13.1. Digitrapper 10.13.2. Bravo System 10.13.3. Stretta 10.13.4. Linx Reflux Management System 10.13.5. Medigus Ultrasonic Surgical Endostapler 10.13.6. Other Devices 10.14. France GERD Drug and devices market Forecast, by Type 10.14.1. Antacids 10.14.2. H2 Receptor Blockers 10.14.3. Proton Pump Inhibitors 10.14.4. Pro-Kinetic Agents 10.15. France GERD Drug and devices market Forecast, by Devices 10.15.1. Digitrapper 10.15.2. Bravo System 10.15.3. Stretta 10.15.4. Linx Reflux Management System 10.15.5. Medigus Ultrasonic Surgical Endostapler 10.15.6. Other Devices 10.16. Italy GERD Drug and devices market Forecast, by Type 10.16.1. Antacids 10.16.2. H2 Receptor Blockers 10.16.3. Proton Pump Inhibitors 10.16.4. Pro-Kinetic Agents 10.17. Italy GERD Drug and devices market Forecast, by Devices 10.17.1. Digitrapper 10.17.2. Bravo System 10.17.3. Stretta 10.17.4. Linx Reflux Management System 10.17.5. Medigus Ultrasonic Surgical Endostapler 10.17.6. Other Devices 10.18. Spain GERD Drug and devices market Forecast, by Type 10.18.1. Antacids 10.18.2. H2 Receptor Blockers 10.18.3. Proton Pump Inhibitors 10.18.4. Pro-Kinetic Agents 10.19. Spain GERD Drug and devices market Forecast, by Devices 10.19.1. Digitrapper 10.19.2. Bravo System 10.19.3. Stretta 10.19.4. Linx Reflux Management System 10.19.5. Medigus Ultrasonic Surgical Endostapler 10.19.6. Other Devices 10.20. Rest of Europe GERD Drug and devices market Forecast, by Type 10.20.1. Antacids 10.20.2. H2 Receptor Blockers 10.20.3. Proton Pump Inhibitors 10.20.4. Pro-Kinetic Agents 10.21. Rest of Europe GERD Drug and devices market Forecast, by Devices 10.21.1. Digitrapper 10.21.2. Bravo System 10.21.3. Stretta 10.21.4. Linx Reflux Management System 10.21.5. Medigus Ultrasonic Surgical Endostapler 10.21.6. Other Devices 10.22. Europe GERD Drug and devices market Attractiveness Analysis 10.22.1. By Type 10.22.2. By Devices 10.23. PEST Analysis 11. Asia Pacific GERD Drug and devices market Analysis 11.1. Key Findings 11.2. Asia Pacific GERD Drug and devices market Overview 11.3. Asia Pacific GERD Drug and devices market Value Share Analysis, by Type 11.4. Asia Pacific GERD Drug and devices market Forecast, by Type 11.4.1. Antacids 11.4.2. H2 Receptor Blockers 11.4.3. Proton Pump Inhibitors 11.4.4. Pro-Kinetic Agents 11.5. Asia Pacific GERD Drug and devices market Value Share Analysis, by Devices 11.6. Asia Pacific GERD Drug and devices market Forecast, by Devices 11.6.1. Digitrapper 11.6.2. Bravo System 11.6.3. Stretta 11.6.4. Linx Reflux Management System 11.6.5. Medigus Ultrasonic Surgical Endostapler 11.6.6. Other Devices 11.7. Asia Pacific GERD Drug and devices market Value Share Analysis, by Country 11.8. Asia Pacific GERD Drug and devices market Forecast, by Country 11.8.1. China 11.8.2. India 11.8.3. Japan 11.8.4. ASEAN 11.8.5. Rest of Asia Pacific 11.9. Asia Pacific GERD Drug and devices market Analysis, by Country/ Sub-region 11.10. China GERD Drug and devices market Forecast, by Type 11.10.1. Antacids 11.10.2. H2 Receptor Blockers 11.10.3. Proton Pump Inhibitors 11.10.4. Pro-Kinetic Agents 11.11. China GERD Drug and devices market Forecast, by Devices 11.11.1. Digitrapper 11.11.2. Bravo System 11.11.3. Stretta 11.11.4. Linx Reflux Management System 11.11.5. Medigus Ultrasonic Surgical Endostapler 11.11.6. Other Devices 11.12. India GERD Drug and devices market Forecast, by Type 11.12.1. Antacids 11.12.2. H2 Receptor Blockers 11.12.3. Proton Pump Inhibitors 11.12.4. Pro-Kinetic Agents 11.13. India GERD Drug and devices market Forecast, by Devices 11.13.1. Digitrapper 11.13.2. Bravo System 11.13.3. Stretta 11.13.4. Linx Reflux Management System 11.13.5. Medigus Ultrasonic Surgical Endostapler 11.13.6. Other Devices 11.14. Japan GERD Drug and devices market Forecast, by Type 11.14.1. Antacids 11.14.2. H2 Receptor Blockers 11.14.3. Proton Pump Inhibitors 11.14.4. Pro-Kinetic Agents 11.15. Japan GERD Drug and devices market Forecast, by Devices 11.15.1. Digitrapper 11.15.2. Bravo System 11.15.3. Stretta 11.15.4. Linx Reflux Management System 11.15.5. Medigus Ultrasonic Surgical Endostapler 11.15.6. Other Devices 11.16. ASEAN GERD Drug and devices market Forecast, by Type 11.16.1. Antacids 11.16.2. H2 Receptor Blockers 11.16.3. Proton Pump Inhibitors 11.16.4. Pro-Kinetic Agents 11.17. ASEAN GERD Drug and devices market Forecast, by Devices 11.17.1. Digitrapper 11.17.2. Bravo System 11.17.3. Stretta 11.17.4. Linx Reflux Management System 11.17.5. Medigus Ultrasonic Surgical Endostapler 11.17.6. Other Devices 11.18. Rest of Asia Pacific GERD Drug and devices market Forecast, by Type 11.18.1. Antacids 11.18.2. H2 Receptor Blockers 11.18.3. Proton Pump Inhibitors 11.18.4. Pro-Kinetic Agents 11.19. Rest of Asia Pacific GERD Drug and devices market Forecast, by Devices 11.19.1. Digitrapper 11.19.2. Bravo System 11.19.3. Stretta 11.19.4. Linx Reflux Management System 11.19.5. Medigus Ultrasonic Surgical Endostapler 11.19.6. Other Devices 11.20. Asia Pacific GERD Drug and devices market Attractiveness Analysis 11.20.1. By Type 11.20.2. By Devices 11.21. PEST Analysis 12. Middle East & Africa GERD Drug and devices market Analysis 12.1. Key Findings 12.2. Middle East & Africa GERD Drug and devices market Overview 12.3. Middle East & Africa GERD Drug and devices market Value Share Analysis, by Type 12.4. Middle East & Africa GERD Drug and devices market Forecast, by Type 12.4.1. Antacids 12.4.2. H2 Receptor Blockers 12.4.3. Proton Pump Inhibitors 12.4.4. Pro-Kinetic Agents 12.5. Middle East & Africa GERD Drug and devices market Value Share Analysis, by Devices 12.6. Middle East & Africa GERD Drug and devices market Forecast, by Devices 12.6.1. Digitrapper 12.6.2. Bravo System 12.6.3. Stretta 12.6.4. Linx Reflux Management System 12.6.5. Medigus Ultrasonic Surgical Endostapler 12.6.6. Other Devices 12.7. Middle East & Africa GERD Drug and devices market Value Share Analysis, by Country 12.8. Middle East & Africa GERD Drug and devices market Forecast, by Country 12.8.1. GCC 12.8.2. South Africa 12.8.3. Rest of Middle East & Africa 12.9. Middle East & Africa GERD Drug and devices market Analysis, by Country/ Sub-region 12.10. GCC GERD Drug and devices market Forecast, by Type 12.10.1. Antacids 12.10.2. H2 Receptor Blockers 12.10.3. Proton Pump Inhibitors 12.10.4. Pro-Kinetic Agents 12.11. GCC GERD Drug and devices market Forecast, by Devices 12.11.1. Digitrapper 12.11.2. Bravo System 12.11.3. Stretta 12.11.4. Linx Reflux Management System 12.11.5. Medigus Ultrasonic Surgical Endostapler 12.11.6. Other Devices 12.12. South Africa GERD Drug and devices market Forecast, by Type 12.12.1. Antacids 12.12.2. H2 Receptor Blockers 12.12.3. Proton Pump Inhibitors 12.12.4. Pro-Kinetic Agents 12.13. South Africa GERD Drug and devices market Forecast, by Devices 12.13.1. Digitrapper 12.13.2. Bravo System 12.13.3. Stretta 12.13.4. Linx Reflux Management System 12.13.5. Medigus Ultrasonic Surgical Endostapler 12.13.6. Other Devices 12.14. Rest of Middle East & Africa GERD Drug and devices market Forecast, by Type 12.14.1. Antacids 12.14.2. H2 Receptor Blockers 12.14.3. Proton Pump Inhibitors 12.14.4. Pro-Kinetic Agents 12.15. Rest of Middle East & Africa GERD Drug and devices market Forecast, by Devices 12.15.1. Digitrapper 12.15.2. Bravo System 12.15.3. Stretta 12.15.4. Linx Reflux Management System 12.15.5. Medigus Ultrasonic Surgical Endostapler 12.15.6. Other Devices 12.16. Middle East & Africa GERD Drug and devices market Attractiveness Analysis 12.16.1. By Type 12.16.2. By Devices 12.17. PEST Analysis 13. South America GERD Drug and devices market Analysis 13.1. Key Findings 13.2. South America GERD Drug and devices market Overview 13.3. South America GERD Drug and devices market Value Share Analysis, by Type 13.4. South America GERD Drug and devices market Forecast, by Type 13.4.1. Antacids 13.4.2. H2 Receptor Blockers 13.4.3. Proton Pump Inhibitors 13.4.4. Pro-Kinetic Agents 13.5. South America GERD Drug and devices market Value Share Analysis, by Devices 13.6. South America GERD Drug and devices market Forecast, by Devices 13.6.1. Digitrapper 13.6.2. Bravo System 13.6.3. Stretta 13.6.4. Linx Reflux Management System 13.6.5. Medigus Ultrasonic Surgical Endostapler 13.6.6. Other Devices 13.7. South America GERD Drug and devices market Value Share Analysis, by Country 13.8. South America GERD Drug and devices market Forecast, by Country 13.8.1. Brazil 13.8.2. Mexico 13.8.3. Rest of South America 13.9. South America GERD Drug and devices market Analysis, by Country/ Sub-region 13.10. Brazil GERD Drug and devices market Forecast, by Type 13.10.1. Antacids 13.10.2. H2 Receptor Blockers 13.10.3. Proton Pump Inhibitors 13.10.4. Pro-Kinetic Agents 13.11. Brazil GERD Drug and devices market Forecast, by Devices 13.11.1. Digitrapper 13.11.2. Bravo System 13.11.3. Stretta 13.11.4. Linx Reflux Management System 13.11.5. Medigus Ultrasonic Surgical Endostapler 13.11.6. Other Devices 13.12. Mexico GERD Drug and devices market Forecast, by Type 13.12.1. Antacids 13.12.2. H2 Receptor Blockers 13.12.3. Proton Pump Inhibitors 13.12.4. Pro-Kinetic Agents 13.13. Mexico GERD Drug and devices market Forecast, by Devices 13.13.1. Digitrapper 13.13.2. Bravo System 13.13.3. Stretta 13.13.4. Linx Reflux Management System 13.13.5. Medigus Ultrasonic Surgical Endostapler 13.13.6. Other Devices 13.14. Rest of South America GERD Drug and devices market Forecast, by Type 13.14.1. Antacids 13.14.2. H2 Receptor Blockers 13.14.3. Proton Pump Inhibitors 13.14.4. Pro-Kinetic Agents 13.15. Rest of South America GERD Drug and devices market Forecast, by Devices 13.15.1. Digitrapper 13.15.2. Bravo System 13.15.3. Stretta 13.15.4. Linx Reflux Management System 13.15.5. Medigus Ultrasonic Surgical Endostapler 13.15.6. Other Devices 13.16. South America GERD Drug and devices market Attractiveness Analysis 13.16.1. By Type 13.16.2. By Devices 13.17. PEST Analysis 14. Company Profiles 14.1. Market Share Analysis, by Company 14.2. Competition Matrix 14.3. Company Profiles: Key Players 14.3.1. Brooks Automation, Inc. 14.3.1.1. Company Overview 14.3.1.2. Financial Overview 14.3.1.3. Business Strategy 14.3.1.4. Recent Developments 14.3.1.5. Manufacturing Footprint 14.3.2. AstraZeneca PLC 14.3.3. Boston Scientific Corporation 14.3.4. Cempra Inc. 14.3.5. Eisai Co., Ltd. 14.3.6. EndoGastric Solutions Inc. 14.3.7. EndoStim Inc. 14.3.8. GlaxoSmithKline Plc 14.3.9. Ironwood Pharmaceuticals, Inc. 14.3.10. Jeil pharmaceutical Co. Ltd. 14.3.11. Johnson & Johnson 14.3.12. Mederi Therapeutics Inc. 14.3.13. Medigus Ltd. 14.3.14. Medtronic Inc. 14.3.15. Merck & CO., Inc. 14.3.16. Novartis AG 14.3.17. Pfizer Inc. 14.3.18. Takeda Pharmaceutical Company Limited 14.3.19. Teva Pharmaceuticals Industries Limited. 14.3.20. Torax Medical 14.3.21. Valeant Pharmaceuticals International, I 14.3.22. Biotix, Inc. 14.3.23. Endress+Hauser Management AG 14.3.24. VISTALAB TECHNOLOGIES, INC. 15. Primary Key Insights

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Request Customization Download Sample